Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn where to sell items for fast cash and declutter your space. Get quick cash for your unwanted belongings.
20,471 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When a founder makes a bold move after a price drop, investors sit up and take notice. This article unpacks what a pu...
A high-profile insider move can ripple through a stock's story. This article breaks down the C3.ai CEO's $4.2 million...
AI jitters are turning discount chains and shampoo makers into the market’s hottest trade, upending traditional defen...
A clear look at a Vanguard mega-cap ETF with a heavy tilt toward four tech giants, what that means for risk and retur...
Investors are torn over a high-growth AI stock. This article breaks down the split, lays out the bull case, and shows...
When big names place bets, markets listen. This piece breaks down what cathie wood buying cerebras could mean for you...
Nvidia topped quarterly estimates with a sizable revenue beat and raised guidance, yet its stock slipped as traders w...
As markets swing, investors ask: is Nvidia a smart buy on the dip? This guide breaks down the risks, the upside, and ...
Red Cat stock faced a sharp move that sparked questions about its future. This article breaks down what can cause a s...
Credit to Credo Technology stock rose on a strong earnings beat, but the path ahead hinges on demand for AI infrastru...
If your financial picture includes W-2 income, rental property, RSUs, and side gigs, tax season can feel like a maze....